MiRxes Singapore's Mirxes Inks Agreements for Cancer Early Detection Tests in China, Indonesia Mirxes signed an MOU to scale up manufacturing of its tests in China and expanded an existing commercialization partnership in Indonesia. In Brief This Week: MiRxes, Oncocyte, OpGen, Biodesix, Element Biosciences, More News items for the week of Aug. 7, 2023 MiRxes Gets $50M in Series D Funding, Applies to Hong Kong Limited Stock Exchange The firm plans to use the investment to scale adoption and penetration of its flagship stomach cancer blood test in Asia-Pacific markets and to develop other assays. MiRxes, PT Elion to Develop Cancer Tests for Indonesian Population As part of the arrangement, PT Elion will validate MiRxes' microRNA-based tests for stomach and lung cancer in an Indonesian cohort. MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations The Singapore-based biotech company will evaluate its miRNA biomarker assay for early detection of pulmonary hypertension as part of the SPHERE study. Jul 7, 2022 MiRxes, Singapore Healthcare Organizations Partner to Develop Multi-Cancer Early Detection Test Jun 7, 2022 MiRxes, BGI Research, MGI Partner on Spatial Genomics in Singapore Oct 13, 2021 MiRxes to Expand miRNA Assay Technology to Multiple Cancer Types, Other Disease Areas Premium Jul 8, 2021 MiRxes Raises $77M in Series C Round to Speed Progress of Early Cancer Detection Tests Jan 19, 2021 MiRxes Receives CE Mark, Singapore Regulatory Approval for Multiplex SARS-CoV-2, Flu Test Nov 4, 2020 Singapore's MiRxes Sets Out to Sell Gastric Cancer Test Across Asia Premium Breaking News Plasmid Transfer Let Cholera Pathogen in Yemen Become Multidrug Resistant, Study Suggests Harbinger Health Raises $140 Million in Series B Financing BioMérieux's BioFire Defense Secures $18.8M US DoD Contract for Infectious Disease Testing Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.